This report presents a brief description and classification of status epilepticus. This neurologic emergency occurs more frequently in young children and elderly adults, although patients of all ages may experience prolonged seizures. The pathophysiology and prognosis of the disorder are presented, as well as a review of drugs commonly used for the treatment of convulsive status epilepticus. The morbidity and mortality of status epilepticus are significant and directly dependent upon prompt and appropriate medical therapy. Advances in understanding various aspects of status epilepticus may lead to improved outcome for affected patients. (J Child Neurol 1994;9(Suppl):2S27-2S35).
Get full access to this article
View all access options for this article.
References
1.
Pellock JM: Status epilepticus, in Pellock JM , Myer EC (eds): Neurologic Emergencies in Infancy and Childhood, 2nd ed. New York, Demos, 1993, pp 167-178.
2.
Epilepsy Foundation of America's Working Group on Status Epilepticus: Treatment of convulsive status epilepticus . JAMA1993;270:854-859.
3.
Hauser WA: Epidemiology, morbidity and mortality of status epilepticus, in Delgado-Escueta AV, Porter RJ, Wasterlain CG (eds): Status Epilepticus: Mechanisms of Brain Damage and Treatment. New York, Raven Press, 1982, pp 3-14.
4.
Hauser WA: Status epilepticus: Epidemiologic considerations. Neurology1990;40(Suppl 2):9-13.
5.
DeLorenzo RJ , Towne AR, Pellock JM, Ko D.: Status epilepticus in children, adults and the elderly. Epilepsia1992;33(4):S15-S25.
6.
Shinnar S., Berg AT, Moshé SL, et al: The risk of seizure recurrence following a first unprovoked seizure in childhood: A prospective study. Pediatrics1990;84:1076-1085.
7.
Leppik IE: Status epilepticus: The next decade. Neurology1990;40(Suppl 2):4-9.
8.
Calmeil LF: De l'epilepsie etudiée sous le rapport de son siege et de son influence sur la production de l'alientation mentale. Thesis, Paris , Didat, 1924.
9.
Gastaut H.: Classification of status epilepticus, in Delgado-Escueta AV, Porter RJ, Wasterlain CG (eds): Status Epilepticus: Mechanisms of Brain Damage and Treatment. New York, Raven Press, 1982, pp 15-36.
10.
Aicardi JF, Chevrie JJ: Convulsive status epilepticus in infants and children: A study of 239 cases . Epilepsia1987;11:187.
11.
Froscher W.: Treatment of Status Epilepticus. Baltimore, University Press, 1979.
12.
Dunn W.: Status epilepticus in children: Etiology, clinical features, and outcome . J Child Neurol1988;3:167-173.
13.
Maytal J., Shinnar S., Moshé SL, Alvarez LA: Low morbity and mortality of status epilepticus in children. Pediatrics1989;83: 323-331.
14.
Phillips SA , Shanahan RJ: Etiology and mortality of status epilepticus in children. Arch Neurol1989;46:74-76.
15.
Hauser WA, Rich SS, Annegers JF, Anderson VE: Seizure recurrence after a first unprovoked seizure: An extended follow-up . Neurology1990;40:1163-1170.
16.
Driscoll SM , Jack RL, Teasley JE, et al: Mortality in childhood status epilepticus, abstracted. Ann Neurol1988;24:318.
17.
Shinnar S., Berg AT, Moshé SL, et al: The risk of seizure recurrence following a first unprovoked seizure in childhood: A prospective study. Pediatrics1990;84:1076-1085.
18.
Driscoll SM , Pellock JM, Towne AR, et al: Recurrent status epilepticus in children, abstracted. Neurology1990;40(Suppl 1): 297.
19.
Lothman E.: The biochemical basis and pathophysiology of status epilepticus. Neurology1990;40(Suppl 2):13-23.
20.
Delgado-Escueta AV, Porter RJ, Wasterlain CG (eds): Status Epilepticus: Mechanisms of Brain Damage and Treatment. New York, Raven Press, 1982.
21.
Moshé SL: Epileptogenesis and the immature brain. Epilepsia1987;28(Suppl 1):S3-S15.
22.
Wasterlain CG : Glucose and energy metabolism of the immature brain during status epilepticus, in Delgado-Escueta AV, Porter RJ, Wasterlain CG (eds): Status Epilepticus: Mechanisms of Brain Damage and Treatment. New York, Raven Press, 1982, pp 241-260.
23.
Dwyer BE, Wasterlain CG, Fajikawa DG, et al: Brain protein metabolism in epilepsy, in Delgado-Escueta AV, Ward AA, Woodburg DM, et al (eds): Basic Mechanisms of the Epilepsies: Molecular and Cellular Approaches . New York, Raven Press, 1986, pp 903-918.
24.
Franck G., Sadzot B., Salmon E., et al: Regional cerebral blood flow and metabolic rates in human focal epilepsy and status epilepticus, in Delgado-Escueta AV, Ward AA, Woodburg DM, et al (eds): Basic Mechanisms of the Epilepsies: Molecular and Cellular Approaches. New York, Raven Press, 1986, pp 935-948.
25.
Roger J., Lob H., Tassinari CA: Status epilepticus, in Magnus O, DeHass L (eds): The Epilepsies. Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology, vol SV. Amsterdam, North Holland, 1974.
26.
Treiman DM, Delgado-Escueta AV: Status epilepticus, in Thompson RA , Green JR (eds): Critical Care of Neurologic and Neurosurgical Emergencies. New York, Raven Press, 1990, pp 101-115.
27.
Meldrum BS, Horton RW: Physiology of status epilepticus in primates. Arch Neurol1973;28:1-9.
28.
Meldrum BS, Brierley JB: Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol1973;28:10-17.
29.
Thompson K. , Wasterlain C.: A model of status epilepticus that produces neuronal necrosis in the immature brain, abstracted. Neurology1994;44:A273.
30.
Towne AR, Pellock JM, Ko D., LeLorenzo RJ: Determinants of mortality in status epilepticus. Epilepsia1994;35:27-34.
31.
Aicardi JF, Barton J.: A pneumoencephalographic demonstration of brain atrophy following status epilepticus . Dev Med Child Neurol1971;13:660-667.
32.
Whitty Cwm: Status epilepticus, in Tyrer JH (ed): The Treatment of Epilepsy. Philadelphia , JB Lippincott, 1980.
33.
Fortner CA, Pellock JM, Towne AR, et al: Morbidity of status epilepticus. Epilepsia, in press.
34.
Boggs JG, Painter JA, DeLorenzo RJ: Analysis of electrocardiographic changes in status epilepticus. Epilepsy Res1993;14: 87-93.
35.
Boggs JG, Painter JA, Wood MA, et al: Signal-averaged electrocardiograms in patients with status epilepticus, abstracted. Neurology1994;44:A205.
36.
Pellock JM: Recent advances concerning status epilepticus. Int Pediatr1990;5:188-195.
37.
Pellock JM: Status epilepticus, in Dodson WE, Pellock JM (eds): Pediatric Epilepsy. New York, Demos, 1993, pp 197-206.
38.
Orlowski JP , Porembha DT, Gallagher BB, et al: Comparison study of intraosseous, central intravenous and peripheral intravenous infusions of emergency drugs . Am J Dis Child1990; 144:112-117.
39.
Simon RP: Physiologic consequences of status epilepticus. Epilepsia1985;26(1):558-566.
40.
Jaitly R., Sgro JA, Towne AR, DeLorenzo RJ: A prospective study of prolonged (24 hour) EEG monitoring in a large population of status epilepticus patients, abstracted. Neurology1994; 44(2):A172.
41.
Wiley E (ed): The Treatment of Epilepsy: Principles and Practice. Malvern, PA, Lea & Febiger, 1992.
42.
Treiman DM: The role of benzodiazepines in the management of status epilepticus . Neurology1990;40(Suppl 2):32-42.
43.
Homan RW, Unwin DH: Benzodiazepines: lorazepam, in Levy RH , Dreifuss FE, Mattson RH, et al (eds): Antiepileptic Drugs3rd ed. New York, Raven Press, 1989, pp 849-854.
44.
Crawford TO , Mitchell WG, Snodgrass SR: Lorazepam in childhood status epilepticus and serial seizures: Effectiveness and tachyphylaxis. Neurology1987;37:190-195.
45.
Deshnukh A. , Wittert W., Schnitzler E., Margutten HH: Lorazepam in the treatment of refractory neonatal seizures. Am J Dis Child1986;140:1042-1044.
46.
Graing DW, McBride MC: Lorazepam versus diazepam for the treatment of status epilepticus . Pediatr Neurol1988;4:358-361.
47.
Lacey DJ, Singer WD, Horowitz SJ, Gilmore H.: Lorazepam therapy of status epilepticus in children and adolescents . J Pediatr1986;198:771-774.
48.
Levy RJ, Krall RL: Treatment of status epilepticus with lorazepam. Arch Neurol1984;41:605-611.
49.
Relling MV, Mulhern RK, Dodge RK, et al: Lorazepam pharmacodynamics and pharmacokinetics in children . J Pediatr1989; 114:641-646.
50.
Graves NM, Kriel RL: Rectal administration of antiepileptic drugs in children. Pediatr Neurol1987;3:321-326.
51.
Enrile-Bacsal F., Delgado-Escueta AV: IV diazepam drip in tonic-clonic status epilepticus, in Delgado-Escueta AV, Porter RJ, Wasterlain CG (eds): Status Epilepticus: Mechanisms of Brain Damage and Treatment. New York, Raven Press, 1982, pp 477-486.
52.
Pellock JM, Dreifuss F., Cloyd JC: Rectal diazepam for the treatment of acute repetitive seizures: An open-label multicenter study, abstract. Neurology1994 ;44(2):A297.
53.
Crisp CB, Gannon R., Krauft F.: Continuous infusion of midazolam hydrochloride to control status epilepticus . Clin Pharm1933;7:322-324.
54.
Rivera R., Segnini M., Baltodano A., Perez V.: Midazolam in the treatment of status epilepticus in children. Crit Care Med1993; 21(7):991-994.
55.
Lombroso CT : The treatment of status epilepticus. Pediatrics1974;53:536-542.
56.
Lockman LA: Treatment of status epilepticus in children. Neurology1990;40(Suppl 2):43-46.
57.
Shaner DM, McCurdy SA, Herring MO, Gabor AJ: Treatment of status epilepticus: A prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology1988;38:202-207.
58.
Wilder BJ, Ramsay RE, Hillmore LJ, et al: Efficacy of intravenous phenytoin in the treatment of status epilepticus: Kinetics of central nervous system penetration. Ann Neurol1977;1: 511-518.
59.
Ramsey RE, Hammond EJ, Perchalski RJ, et al: Brain uptake of phenytoin, phenobarbital, and clonazepam. Arch Neurol1979; 36:535-539.
60.
Dodson WE, Pellock JM (eds): Pediatric Epilepsy: Diagnosis and Therapy. New York, Demos, 1993 .
61.
Cranford RE , Leppick IE, Patrick B., et al: Intravenous phenytoin: Clinical and pharmacokinetic aspects. Neurology1979;29: 1474-1479.
62.
Wilensky AJ , Lowden JA: Inadequate serum levels after intramuscular administration of diphenylhydantoin. Neurology1973;23:318-321.
63.
Leppik IE, Boucher BA, Wilder BJ, Murthy VS, et al: Pharmacokinetics and safety of a phenytoin product given IV or IM in patients. Neurology1990;40:456-460.
64.
Raskin MC, Younger C., Penowish P.: Pentobarbital treatment of refractory status epilepticus. Neurology1987;37:500-503.
65.
VanNess PC: Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia1990;31:61-67.
66.
Shields WD: Status epilepticus. Pediatr Clin North Am1989; 36:383-393.
67.
Lemmen LJ, Klasen M., Duiser B.: Intravenous lidocaine in the treatment of convulsions. JAMA1978;239:2025.
68.
Berkovic SF , Andermann F., Griberman A., et al: Valproate prevents the recurrence of absence status. Neurology1989;39: 1294-1297.
69.
Holmes GL: Drug of choice for status epilepticus. J Epilepsy1990;3:1.
70.
Gabor AJ: Lorazepam versus phenobarbital: Candidates for drug of choice for treatment of status epilepticus. J Epilepsy1990;3:3-6.
71.
Mitchell V. , Crawford TO: Lorazepam is the treatment of choice for status epilepticus. J Epilepsy1990;3:7-10.
72.
Porter RJ, Peury JK: Petit mal status, in Delgado-Escueta AV, Wasterlain CG, Treiman DM , et al (eds): Status EpilepticusNew York, Raven Press, 1987, pp 61-67.
73.
McBride MC, Dooling EC, Oppenheimer EY: Complex partial status epilepticus in young children. Ann Neurol1981;9:526-530.
74.
Treiman DM, Delgado-Escueta A.: Complex partial status epilepticus, in Delgado-Escueta AV, Wasterlain CG, Treiman DM, et al (eds): Status Epilepticus . New York, Raven Press, 1987, pp 69-81.
